Table 2 Area under the curve (AUC) values with 95% confidence intervals for baseline and 2-month signatures for prediction of treatment outcome at 2 months (Early Responders) and at 6 months (TB Cures).

From: Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes

Validation

Outcome

Time of prediction

N

Patient characteristics

Transcriptional biomarkers

Patient + transcriptional biomarkers

N

Patient characteristics

Protein biomarkers

Patient + protein biomarkers

Internal

TB Cures (6 months)

Baseline

90

0.78 (0.68–0.88)

0.78 (0.69–0.88)

0.89 (0.83–0.95)

83

0.78 (0.68–0.88)

0.69 (0.57–0.81)

0.83 (0.74–0.92)

 

TB Cures (6 months)

2 months

67

0.83 (0.71–0.94)

0.84 (0.73–0.95)

0.97 (0.91–1.00)

59

0.74 (0.59–0.89)

0.68 (0.51–0.85)

0.68 (0.51–0.84)

 

Early responders (2 months)

Baseline

90

0.77 (0.66–0.87)

0.67 (0.55–0.79)

0.97 (0.94–1.00)

83

0.74 (0.63–0.85)

0.78 (0.68–0.88)

0.88 (0.80–0.95)

External

TB Cure (6 months)

Baseline

84

0.71 (0.58–0.85)

0.74 (0.54–0.94)

0.92 (0.84–1.00)